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Abstract
Background: Streptococcus suis causes invasive infections in pigs and occasionally in humans. The host innate immune
system plays a major role in counteracting S. suis infections. The main components of S. suis able to activate the innate
immune system likely include cell wall constituents that may be released during growth or after cell wall integrity loss,
however characterization of these components is still limited.
Methology/Principal Findings: A concentrated very potent innate immunity activating supernatant of penicillin-treated
S. suis was SDS-PAGE fractionated and tested for porcine peripheral blood mononucleated cell (PBMC) stimulating activity
using cytokine gene transcript analysis. More than half of the 24 tested fractions increased IL-1b and IL-8 cytokine gene
transcript levels in porcine PBMCs. Mass spectrometry of the active fractions indicated 24 proteins including 9 lipoproteins.
Genetic inactivation of a putative prolipoprotein diacylglyceryl transferase (Lgt) gene resulted in deficient lipoprotein
synthesis as evidenced by palmitate labeling. The Lgt mutant showed strongly reduced activation of porcine PBMCs,
indicating that lipoproteins are dominant porcine PBMC activating molecules of S. suis.
Conclusion/Significance: This study for the first time identifies and characterizes lipoproteins of S. suis as major activators of
the innate immune system of the pig. In addition, we provide evidence that Lgt processing of lipoproteins is required for
lipoprotein mediated innate immune activation.
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Introduction
Streptococcus suis causes severe infections in pigs, including
meningitis, septicemia, endocarditis, pneumonia and arthritis.
Occasionally, S. suis infects humans as well, resulting in compara-
ble disease manifestations as are seen in pigs [1,2,3]. To date, 33
serotypes of S. suis have been described based on differences in
polysaccharide capsule. Isolates even of the same serotype may
vary in virulence. The majority of isolates that causes disease
belong to serotype 2, although in Europe serotype 9 isolates are
emerging [4,5,6].
Based on the existence of a strong inflammatory response
during an acute S. suis infection, a significant activation of innate
immunity is expected early after infection. The innate immune
system uses pattern recognition receptors (PRRs) to recognize
pathogen associated molecular patterns (PAMPs) of microbes. One
group of PRRs able to sense a diverse set of bacterial PAMPs is the
Toll-like receptor (TLR) family. Activation of these TLRs results
in nuclear translocation of transcription factors (e.g. nuclear factor
kappa B, NF-kB) which ultimately causes enhanced production of
pro-inflammatory cytokines, chemokines and antimicrobial pep-
tides. Besides these direct mechanisms to eliminate invading
microbes, the innate immune system plays a decisive role in
initiating and strengthening humoral and cell-mediated protection.
The capsule of S. suis may be one of the first structures to be
recognized by the innate immune system. However, capsule by
itself is a poor activator of the innate immune system [7]. Capsule-
deficient S. suis strains display even higher levels of innate activa-
tion compared to wild type strains in human monocytes and
macrophages [7,8]. The main components of S. suis involved in
activating the innate immune system therefore likely include cell
wall or cell membrane constituents. Indeed, cell wall extracts of
S. suis have been shown to be potent cytokine inducers in murine
macrophages, human endothelial brain cells, human monocytes
and in a porcine whole blood model [8,9,10,11]. Furthermore, we
recently provided evidence that components of S. suis released after
cell wall integrity loss specifically activate the human TLR2/6
complex that mostly recognizes bacterial lipoproteins [12].
Lipoproteins of Gram-positive bacteria are processed by two
key enzymes; the prolipoprotein diacylglyceryl transferase (Lgt)
enzyme and the lipoprotein signal peptidase (Lsp) enzyme. The
Lgt enzyme recognizes a so-called lipobox motif (LXXC) in the C-
terminal region of the signal peptide of a premature lipoprotein
and transfers a diacylglyceryl moiety to the cysteine residue of the
lipobox [13,14]. Subsequently, the Lsp enzyme cleaves the signal
peptide resulting in a mature lipoprotein [15,16]. Lipid modifica-
tion of Gram-positive bacterial lipoproteins via Lgt has been
described to be essential for innate immune activation [17,18].
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22299The objective of this study was to identify components of S. suis
that activate porcine peripheral blood mononucleated cells
(PBMCs). We used mass spectrometry and genetically defined
lipoprotein-processing defective strains as research instruments.
Results
S. suis activates porcine PBMCs efficiently
Porcine PBMCs were isolated from pig blood and incubated
with S. suis and collected bacterial culture supernatant. Penicillin
was used to enhance the possible release of PBMC activating
components. PBMC activation was determined by measuring
changes in IL-1b and IL-8 mRNA transcripts using qRT-PCR.
Stimulation of PBMCs with penicillin treated S. suis increased IL-
1b and IL-8 cytokine transcripts to similar levels as obtained after
stimulation with FSL-1, a synthetic lipopeptide (Fig. 1). Activating
components were not exclusively cell bound since bacterial culture
supernatant stimulated the PBMCs as well (Fig. 1). These results
indicate that penicillin-treated S. suis is sensed efficiently by the
porcine innate immune system and that activating component(s)
are released into the supernatant.
Identification of innate immunity activating proteins
To gain more insights into the nature of the porcine PBMC
activating component(s), we concentrated the supernatant of
penicillin-treated S. suis and size fractionated it into 24 fractions
by SDS-PAGE. The obtained fractions were analyzed for their
ability to stimulate porcine PBMCs. More than half of the
fractions increased IL-1b and IL-8 cytokine transcript levels as
measured by qRT-PCR (Fig. 2A, B). The kinetics of the changes in
IL-1b and IL-8 mRNA were very similar. The fractions that
caused a more than 5-fold increase in IL-1b and IL-8 mRNA were
individually analyzed by mass spectrometry. Mascot scores were
determined using the identified peptides in all the fractions
simultaneously to increase the sensitivity and specificity of the
analysis. A total of 24 S. suis proteins with MASCOT scores .50
(Table 1) were identified. Among these 24 proteins, nine (37.5%)
putative lipoproteins were present, including two lipoproteins
previously shown to be recognized by porcine convalescent sera
[19,20]. In the genome of S. suis strain P1/7, 45 putative
lipoprotein coding genes are present (Table S1, [21]) which
corresponds to 2.5% of the proteome [21]. This large enrichment
of lipoproteins in the porcine PBMC activating fractions suggests
that S. suis lipoproteins contribute to the observed PBMC
activation.
Porcine PBMC activating fractions also activate human
TLR2/6 expressing HeLa cells
To investigate the specificity of the (lipo)proteins for porcine
PBMC activation, we analyzed the same fractions as used in the
PBMC experiment to stimulate HeLa cells expressing human
TLR2/6 and a NF-kB luciferase reporter [22]. Human TLR2/6
recognizes bacterial lipoproteins including those of S. suis [12]. As
shown in Fig. 2C, all fractions able to initiate a porcine IL-1b and
IL-8 response (Fig. 2A, B) also activated the TLR2/6-expressing
HeLa cells (Fig. 2C), while fractions with low activity yielded a
poor response in both porcine PBMCs and human TLR2/6-
expressing cells. None of the tested fractions was able to activate
transfected HeLa cells lacking TLR2/6 expression (Fig. 2D). The
comparable activation of the porcine PBMCs and the human
TLR2/6 cell system strongly suggests that lipoproteins have a
major role in activating porcine PBMCs, although these results do
not exclude that also non-lipoproteins activate porcine PBMCs.
Generation and characterization of a S. suisDlgt mutant
To distinguish between lipoprotein and non-lipoprotein medi-
ated innate immune activation of porcine PBMCs, we constructed
a mutant S. suis serotype 9 isolate deficient in the expression of the
lipoprotein processing enzyme Lgt. Lgt in Gram-positive bacteria
is required for lipid modification of the cysteine residue present
within the lipobox of prelipoproteins. In the genome of S. suis
serotype 2 strain P1/7 gene SSU_1418 had been annotated to
encode the Lgt protein. This putative Lgt protein showed 67%
amino acid sequence identity to the Lgt protein of S. pneumoniae
strain D39 [23]. The lgt gene is the second gene transcribed of an
operon expressing 4 genes also encoding two putative exported
proteins and a phosphorylase enzyme. We inactivated the
corresponding lgt gene in S. suis serotype 9 strain 8067 by
Figure 1. Porcine PBMC stimulation with wild type S. suis.
Porcine PBMCs were stimulated with whole S. suis strain 8067 bacteria
(cells) in the presence of penicillin or with supernatant (sup.) derived
from penicillin treated bacteria. At 2 (light grey bar) and 4 h (dark grey
bar) post stimulation IL-1b (A) and IL-8 (B) mRNA expression levels were
determined by quantitative real time PCR. The diacylatedlipopeptide
FSL was used as a positive control. Data represent fold inductions
calculated by dividing the normalized cytokine levels of stimulated cells
by the normalized cytokine levels of medium-stimulated negative
control cells. Values represent the mean 6 SD of two experiments
performed in duplicate.
doi:10.1371/journal.pone.0022299.g001
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positive control was made by re-introducing an intact lgt gene in
the Dlgt mutant strain by plasmid complementation generating
Dlgt::pGA14-lgt. As a negative control we complemented the Dlgt
mutant with vector lacking the lgt insert, generating Dlgt::pGA14-
cm. Inactivation of lgt resulted in viable S. suis bacteria able to grow
efficiently in THB after a slightly increased lag phase (Fig. 3).
To verify that lipoprotein processing had been abolished in
the Dlgt mutant, lipidation of lipoproteins in the wild type and
mutant was analyzed. Bacteria were grown in the presence of
[
3H]palmitic acid and subsequently treated with penicillin.
Similar amounts of protein were released from wild type and
(complemented) Dlgt mutant bacteria (Fig. 4). Several radiola-
beled proteins were detected in the supernatant of the wild type
and the Dlgt::pGA14-lgt mutant (Fig. 4), whereas no radiola-
beled (lipo)proteins were detected in the supernatant of the Dlgt
mutant and the Dlgt::pGA14-cm mutant. These data confirm
that Lgt is responsible for lipid modification of prelipoproteins
in S. suis.
Disruption of lgt abolishes activation of human TLR2/6
To investigate whether lipid modification of S. suis prelipopro-
teins is a prerequisite for human TLR2/6 activation, we compared
the abilities of the (penicillin-treated) wild type, Dlgt mutant and
the complemented Dlgt mutant strains to activate HeLa cells
expressing human TLR2/6. Both S. suis wild type and the
Dlgt::pGA14-lgt mutant induced significant TLR2/6 activation
(Fig. 5A), in contrast to the Dlgt mutant and the Dlgt::pGA14-cm
strain. In all cases, stimulation of HeLa cells transfected with the
vectors lacking the TLR gene yielded only background levels of
NF-kB activity (Fig. 5B). These data indicate that the presence of a
protein bound lipid moiety is a prerequisite for activation of
human TLR2/6 and that the S. suis lipoproteins are the primary
ligands that activate the human TLR2/6 complex.
Figure 2. Porcine PBMC and human TLR2/6 stimulation of innate immunity activating fractions. Porcine PBMCs were stimulated with an
innate immunity activating fraction of S. suis strain 8067 (concentrated supernatant of penicillin treated bacteria) subdivided into 24 fractions of
different molecular sizes. At 4 h post stimulation IL-1b (A) and IL-8 (B) mRNA expression levels were determined by quantitative real time PCR. HeLa
57A cells expressing human TLR2/6 (C), and control cells transfected with vector without insert (D) were stimulated (5 h) with the same 24 fractions.
Data represent relative fold activation calculated by dividing the normalized test samples by the normalized activity of medium-stimulated negative
control samples. Values represent the mean 6 SD of two experiments performed in duplicate. Fractions that induced .5 fold porcine PBMC
activation were analyzed by mass spectrometry (Table 1).
doi:10.1371/journal.pone.0022299.g002
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PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e22299Inactivation of lgt reduces PBMC activation
In contrast to the transfected HeLa cells expressing human
TLR2/6, porcine PBMC express multiple innate immune receptors
that may respond to various S. suis components. To assess the
contribution of lipoproteins to PBMC activation, we stimulated
porcine PBMCs with (penicillin-treated) supernatants and cells of
wild type, Dlgt mutant, Dlgt::pGA14-cm mutant and Dlgt::pGA14-lgt
mutant bacteria. Stimulation with the wild type and the
Dlgt::pGA14-lgt mutant bacterial supernatants resulted in efficient
induction of IL-1b and IL-8 mRNA at 2 h and 4 h post stimulation
(Figs. 6A and B). As expected, only minimal induction of IL-1b and
IL-8 mRNA was observed after stimulation with the Dlgt mutant
and Dlgt::pGA14-cm mutant derived supernatant. In line with the
activationkineticsofthesupernatants,PBMCsstimulationwithwild
type and Dlgt::pGA14-lgt mutant bacteria also resulted in efficient
induction of IL-1b and IL-8 mRNA at 2 h and 4 h post stimulation
(Fig. 6C and D). The IL-1b and IL-8 mRNA levels induced by the
Dlgt mutant and the Dlgt::pGA14-cm mutant were once more
strongly reduced compared to the wild type strain especially at 2 h
post stimulation. These results suggest S. suis lipoproteins as the
principal activators of the porcine PBMC innate immune response.
Contribution lipoproteins in activating porcine PBMCs in
the absence of penicillin
The above results were obtained with penicillin-treated S. suis to
enhance the release, and enable the identification, of immune
activating bacterial factors. To assess the contribution of lipopro-
teins as activators of the porcine PBMC response in the absence of
antibiotics, we stimulated porcine PBMCs with live S. suis and
supernatants of S. suis grown to stationary phase without penicillin.
Stimulation of PBMCs with both cells and supernatant of wild type
and Dlgt::pGA14-lgt mutant bacteria resulted in efficient induction
ofIL-1b and IL-8 mRNA (Fig.6E–H).Much lessinductionofIL-1b
and IL-8 mRNA was observed after stimulation with the Dlgt
mutant and the Dlgt::pGA14-cm mutant cells and supernatants,
consistent with the results obtained in the presence of penicillin.
Together, these results indicate that S. suis lipoproteins are major
activators of the innate immune system of the pig.
Discussion
In the present study we identified 9 S. suis lipoproteins within a
fraction able to activate porcine PBMCs efficiently. Disruption of
the lgt gene required for lipoprotein synthesis strongly reduced
activation of porcine PBMCs. This effect was restored after
complementation of the gene defect. Altogether, these results
provide conclusive evidence that lipoproteins are potent and
dominant innate immunity activating molecules of S. suis.
The identification of S. suis lipoproteins as major activators of
porcine PBMCs resulted from detailed analysis of active fractions of
bacterial culture supernatant. Mass spectrometry results and the
finding that similar fractions activated porcine PBMCs and the
human TLR2/6 complex pointed towards possible lipoproteins as
activating molecules. We possibly only identified the most
abundantly expressed or released lipoproteins of S. suis by mass
spectrometry.Asshownforseveralbacterial speciesincludingS.suis,
expression levels may vary between different lipoproteins and are
influenced by the bacterial environment. In a recent study, three
divalent-cation-binding lipoproteins of S. suis were shown to be up
regulated after divalent-cation deprivation in vitro [24] and a fourth
divalent-cation-binding lipoprotein was shown to be up regulated in
mice [20]. Of the 9 lipoproteins we identified here, the basic
membrane lipoprotein (SSU0934 in S. suis P1/7) and a putative
high affinity metal binding lipoprotein (SSU1869 in S. suis P1/7)
have been demonstrated to be recognized by convalescent pig sera
[19,20], indicating their expression and immunogenicity in vivo.
Porcine PBMCs are expected to express a wide range of PRRs
including TLRs. Activation of TLRs by bacterial PAMPs generally
results in nuclear translocation of NF-kB followed by transcription
of pro-inflammatory cytokines and chemokines such as IL-1b and
IL-8. Efficient activation and differences in transcript levels of IL-
Figure 3. Growth of wild type and Dlgt mutant bacteria. Growth
of wild type, Dlgt mutant, and the complemented Dlgt mutant
(Dlgt::pGA14-cm; Dlgt::pGA14-lgt) bacteria was assessed in THB by
following optical densities in time.
doi:10.1371/journal.pone.0022299.g003
Figure 4. Lipidation of wild type and Dlgt mutant bacteria.
Lipidation was assessed by incubating the wild type and mutant
bacteria with [
3H]palmitic acid, followed by penicillin treatment and
SDS-PAGE. Lipidation was visualized using autoradiography. As a
control, total protein release of wild type and mutant bacteria was
visualized with Silver staining.
doi:10.1371/journal.pone.0022299.g004
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ratio of 1:1 at the start of infection and as early as 2 and 4 h post
infection. As expected, other NF-kB dependent cytokines, such as
IL-6, TNF-a and IL-10 showed similar kinetics when compared to
IL-1b and IL-8 expression profiles (Fig. S1). Cell damage at
prolonged infection prevented measurements of accurate cytokine
release into the medium. The increase in IL-1b and IL-8 in the
porcine PBMCs is likely mediated via porcine TLR2/6, although
this could not be measured as the porcine TLR read out systems
have not been validated in a porcine cell background. However, we
successfully demonstrated that the identified S. suis lipoproteins
activate human TLR2/6, which has a high level of sequence
identity with porcine TLR2/6.
During this study, we initially used penicillin to enhance the
release of possible innate immunity activating components of
S. suis. Penicillin inactivates the penicillin binding proteins essential
for the crosslinking of bacterial peptidoglycan, skewing the release
of components normally tightly attached to the cell wall or cell
membrane. This procedure resulted in increased release of
(lipo)proteins in the culture supernatant and facilitated the
identification of the innate immunity activating (lipo)proteins.
The effect of increased innate sensing after penicillin treatment has
also been reported for S. pneumoniae [25]. Our finding that PBMC
activation also occurred in the absence of penicillin (Fig. 6)
excludes adverse effects of penicillin (e.g. cell lysis) on the immune
activation. In the absence of penicillin, the effects of immune
activation were most pronounced during stationary growth phase.
This likely explains the lack of activation of human TLR2/6 by
logarithmic phase-derived bacteria [12].
In S. suis a significant group of lipoproteins is predicted to have
substrate binding and transport functions (Table S1) which
suggests lipoproteins to be involved in nutrient acquisition.
Interestingly, the in vitro growth data of the Dlgt mutant bacteria
suggest that nutrient acquisition mediated by lipoproteins is not
critical for growth in rich media such as THB or that lipid
modification of lipoproteins is not essential for lipoprotein
function. The in vitro growth ability of the S. suis Dlgt mutant
bacteria resembles observation of several other lgt mutants in
Streptococcal species such as S. pneumoniae, S. equi, S. agalactiae,
S. sanguinis and S. uberis [17,26,27,28,29]. Probably lipoproteins
without lipid moiety are still anchored in the bacterial membrane
and able to fulfill (partly) their roles in nutrient acquisition. The
observations of reduced innate immune activation, observed for
the S. suis Dlgt mutant strain, is in agreement with observations in
other Gram-positive bacterial species, including Staphyloccoccus
aureus, Listeria monocytogenes and S. agalactiae [17,18,30].
On the basis of our results, the absence of lipoprotein lipidation
may benefit S. suis as it may aid to evade sensing by the innate
immune system. On the other hand, the absence of lipoprotein
lipidation might affect lipoprotein functionality, which may affect
in vivo growth and virulence characteristics, interactions with
components in the host, and interactions with other surrounding S.
suis bacteria. These growth effects complicate the interpretation of
in vivo studies on the effect of S. suis on the innate immune
response. In S. sanguinis and S. pneumoniae inactivation of Lgt
processing of lipoproteins have been shown to moderately reduce
virulence [26,27]. In S. agalactiae and S. aureus Dlgt mutant bacteria
became hypervirulent at a low dose [17,31]. Whether virulence of
the S. suis Dlgt mutant is affected compared to wild type bacteria
and whether this is caused by an altered innate immune response
or growth characteristics awaits further study.
Materials and Methods
Ethics Statement
Fresh porcine blood was obtained in accordance with a protocol
(2008120.a) approved by the Animal Experiments Committee of
the Central Veterinary Institute (Lelystad, The Netherlands), in
Figure 5. TLR2/6 activating capacity of wild type and Dlgt
mutant bacteria. HeLa 57A cells expressing human TLR2/6 (A) and
control cells transfected with vector without insert (B) were stimulated
with wild type, Dlgt, Dlgt::pGA14-cm, and Dlgt::pGA14-lgt mutant
bacteria in the presence of penicillin (30 mg/ml). At 5 h post stimulation,
NF-kB luciferase activity was determined. The diacylated lipopeptide
FSL was used as a positive control. Data represent relative luciferase
activity calculated by dividing the normalized activity of the test
samples by the normalized activity of medium-stimulated negative
control samples. Values represent the mean 6 SD of three independent
experiments performed in duplicate. * P,0.05 compared to wild type
level.
doi:10.1371/journal.pone.0022299.g005
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code: 2008149).
Bacterial strains and growth conditions
In this study we used a serotype 9 strain (strain 8067, virulent
pig isolate, Smith et al., unpublished results), which is previously
shown to activate the innate immune system via human TLR2/6
more efficiently compared to serotype 2 strains [12]. Wild type
bacteria, isogenic mutants as well as complemented mutant strains
were grown on Colombia agar plates (Oxoid Ltd, London, United
Kingdom) containing 6% horse blood at 5% CO2 and 37uC.
Liquid cultures were grown in Todd-Hewitt broth (THB) (Oxoid
Ltd.) for 18 h at 37uC without agitation. Escherichia coli were grown
on Luria-Bertani (LB) agar plates or in LB broth. When necessary,
antibiotics were added to culture media at the following
concentrations: for E. coli, ampicillin 100 mg/ml; chloramphenicol
8 mg/ml and spectinomycin 100 mg/ml; for S. suis, chloramphen-
icol 5 mg/ml and spectinomycin 100 mg/ml. For use in stimulation
experiments, bacteria were pelleted by centrifugation at 4,5006g
for 10 min and resuspended to 1.0610
9 CFU/ml in Dulbecco’s
phosphate buffered saline (D-PBS).
General DNA techniques
Genomic DNA from S. suis was isolated as described previously
[32]. PCRs were conducted with Phusion High-Fidelity DNA
polymerase (BIOKE, Leiden, The Netherlands). Plasmid DNA
was isolated with the Plasmid DNA Purification System (Promega,
Leiden, The Netherlands). DNA purifications were performed
with the Zymogen clean up kits (BaseClear, Leiden, The
Netherlands). Ligations were performed with T4 DNA ligase
(Promega) and ligation mixtures were used to transform E. coli.
Plasmids were introduced into S. suis via electroporation [33].
Generation of Dlgt mutant
Primers used in this study are listed in Table S2. Primers 1 and
4 were used to amplify a fragment of the chromosomal DNA of
strain 8067 containing the intact lgt gene flanked on both sides by
1.5 kb regions. This fragment was ligated to the blunt cloning
vector pJET1.2 (Fermentas, St. Leon-Rot, Germany) and ligation
mixtures were transformed to E. coli. Plasmid DNA (designated
pJET-lgt) obtained from transformants was then used to replace an
internal fragment (about 300 bp) of lgt by a Spc resistance cassette.
To do this, we used an inverse PCR strategy on pJET-lgt using
primers 2 and 3. In addition, the Spc cassette was amplified from
pGA14-spc [22] using primers 9 and 10. The amplified fragments
were digested with XmaI and SalI and ligated together. Ligation
mixtures were introduced into E. coli to generate pJET-lgt-spc. The
entire insert fragment of pJET-lgt-spc was subsequently amplified
using primers 1 and 4 and ligated to the thermo sensitive shuttle
vector pSET5 [34], which was linerialized with the SmaI restriction
enzyme, generating pSET5-lgt-spc. The pSET5-lgt-spc plasmid was
then introduced into S. suis strain 8067 by electroporation and
transformants were selected on Columbia agar plates at 30uCi n
the presence of spectinomycin. Several individual colonies were
grown overnight in THB (10 ml) containing spectinomycin at
30uC. The overnight cultures were then diluted 1:100 in THB
without antibiotics and incubated for 4 h at 38uC. Cultures were
serially diluted on Columbia agar plates containing spectinomycin
at 38uC to select for chromosomal integration. Individual colonies
that had lost the vector mediated chloramphenicol resistance were
confirmed to have the expected mutant genotype by PCR using
primer pairs 5,6 and 7,8 as well as by Southern blotting.
Complementation of the Dlgt mutant
To complement the Dlgt mutant with an intact lgt gene, we
constructed an expression plasmid containing the wild type lgt
gene including its putative promoter. Primers 13 and 14 were used
to amplify the lgt fragment, which was cloned into pJET1.2
generating pJET1.2-lgt-expr. Subsequently, pJET1.2-lgt-expr was
digested with SmaI and SalI and the lgt fragment was purified and
cloned into pGA14 [35] digested with SmaI and SalI, generating
pGA14-lgt-expr. Finally, the chloramphenicol resistance gene (cm)
of pSET5, amplified with primers 15 and 16 and digested with
SalI, was introduced at the SalI site of pGA14-lgt-expr to yield
pGA14-lgt-expr-cm. As a negative control, cm was introduced in
pGA14 digested with SalI, generating pGA14-cm. Both plasmids
were subsequently introduced into the Dlgt mutant generating
Dlgt::pGA14-lgt and Dlgt::pGA14-cm respectively. RNA expression
of the lgt gene in the Dlgt::pGA14-lgt mutant was confirmed by
quantitative real time PCR.
Growth analysis
Overnight cultures of wild type and mutant bacteria were 1:100
diluted in fresh THB and optical density at 600 nm (OD600)o f
400 ml samples was followed in time using the Bioscreen C
(Thermo Scientific, Breda, The Netherlands) at 37uC. Overnight
cultures of wild type, Dlgt mutant and complemented mutants had
similar OD600 values and contained the same amounts of CFU.
[
3H]palmitate labeling
Bacteria were grown for 18 h at 37uC in THB, pelleted,
resuspended to 1.0610
9 CFU/ml in D-PBS and then diluted 1:20
in chemical defined medium (CDM) consisting of a 1:1 mixture of
HAM-F12 nutrient mixture (Invitrogen, Breda, The Netherlands)
and NCTC-109 medium (Sigma-Aldrich, Zwijndrecht, The Nether-
lands) containing 10 mCi/ml [9,10-3
H]palmitic acid (Perkin Elmer,
Groningen, The Netherlands). At an optical density of 0.4 (600 nm),
penicillin G (Sigma-Aldrich) was added to the culture to a final
concentration of 30 mg/ml. After 2 h of incubation at 37uC, the
bacteria and medium were separated by centrifugation (4,5006g,
10 min) and the supernatant was 40 times volume concentrated by
Amicon Ultra-15 centrifugal filter devices with a 3 kD cut-off
(Millipore, Amsterdam, The Netherlands). Subsequently, LDS
Sample Buffer (Invitrogen) was added to the concentrated fraction
and 30 ml samples were separated using SDS-PAGE. Finally, the gel
was fixed, dried, and exposed to an autoradiography film for 24 h.
Generation of (concentrated) bacterial supernatant
Wild type 8067, Dlgt mutant and complemented Dlgt mutant
strains were grown for 18 h at 37uC in THB, pelleted,
resuspended to 1.0610
9 CFU/ml in D-PBS and diluted 1:20 in
Figure 6. Porcine PBMC activating capacity of wild type and Dlgt mutant bacteria. Porcine PBMCs were stimulated with wild type, Dlgt,
Dlgt::pGA14-cm, and Dlgt::pGA14-lgt mutant bacteria. PBMCs were stimulated with supernatants derived from penicillin treated bacteria (A, B), cells in
the presence of penicillin (C, D), supernatants of stationary phase grown bacteria in the absence of penicillin (E, F) and cells in the absence of
penicillin (G, H). At 2 h (light grey bar) and 4 h (dark grey bar) after stimulation, IL-1b (A, C, E, G) and IL-8 (B, D, F, H) mRNA levels were determined.
The diacylated lipopeptide FSL was used as a positive control. Data represent relative fold activation calculated by dividing the normalized activity of
the test samples by the normalized activity of medium-stimulated negative control samples. Values represent the mean 6 SD of three independent
experiments performed in duplicate. * P,0.05 compared to wild type level.
doi:10.1371/journal.pone.0022299.g006
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penicillin G (final concentration of 30 mg/ml) to cultures when
OD600 values reached 0.4. After 2 h of incubation at 37uC, the
bacteria and medium were separated by centrifugation (4,5006g,
10 min) and the supernatants were 0.2 mm filter sterilized.
Stationary phase-derived supernatant was obtained by incubating
1:20 diluted CDM cultures for 24 h at 37uC followed by
centrifugation (4,5006g, 10 min) and filtration (0.2 mm). Super-
natants were directly used for PBMC stimulation or used for
further concentration. For this, 10% TCA w/v was added to the
supernatants followed by overnight incubation at 4uC. After
centrifugation at 30,0006 g for 30 min, the pellets were washed
with 100% acetone and air dried. Finally, protein pellets were
dissolved in LDS Sample Buffer.
Identification of proteins within crude immune
stimulatory fraction
Proteins (1 mg) present in a concentrated bacterial supernatant
of S. suis strain 8067 were separated on a 10% SDS-polyacryl-
amide gel (15 cm in length, 12 cm wide) under non-reducing
conditions (no boiling). One cm of the gel was stained with the
Silver staining kit Plus One from GE Healthcare (Uppsala,
Sweden) and the remaining gel was cut into 0.5 cm strips of 24
different molecular size ranges. Each strip was homogenized with
a mortar in a 1% w/v SDS solution to solubilize proteins. Gel
residue was removed by centrifugation (12,0006g, 10 min) and
five volumes of cold acetone were added to the supernatant. After
overnight incubation at 220uC, precipitate was collected by
centrifugation (12,0006g 4uC for 10 min). Pellets were dissolved in
200 ml of 10 mM Tris-HCl pH 8. Fractions (50 ml) were tested for
activity using porcine PBMCs and human TLR2/6 expressing
HeLa 57A cells. Fractions that showed .5 fold porcine PBMC
activation were once more separated on a 4–12% polyacrylamide
gel (Invitrogen), stained with SimpleBlue Safe Stain (Invitrogen),
excised from the gel, and identified with mass spectrometry.
Briefly, proteins were reduced with dithiothreitol, alkylated with
iodoacetamide, and digested with trypsin (Roche) as described
[36]. Samples were subjected to nanoflow LC (Eksigent) using C18
reverse phase trap columns (Phenomenex; column dimensions
2c m 6100 mm, packed in-house) and subsequently separated
on C18 analytical columns (Reprosil; column dimensions,
20 cm650 mm; packed in-house) using a linear gradient from 0
to 40% B (A=0.1 M acetic acid; B=95% (v/v) acetonitrile,
0.1 M acetic acid) in 60 min and at a constant flow rate of 150 nl/
min. Column eluate was directly coupled to a LTQ-Orbitrap-XL
mass spectrometer (Thermo Fisher Scientific) operating in positive
mode, using Lock spray internal calibration. Data were processed
and subjected to database searches using MASCOT software
(Matrixscience) against Swiss Prot and non-redundant NCBI
database with a 10 ppm mass tolerance of precursor and 0.8 Da
for the fragment ion.
PBMC isolation and stimulation
Blood of three to four week old piglets from a specific pathogen
free (SPF) herd was aseptically collected and mixed with heparin
(LEO Pharma, Breda, Netherlands) to a final concentration of 5
IE/ml. Subsequently, PBMCs were isolated with lymphoprep
tubes (Lucron Bioproducts, Gennep, Netherlands), according the
manufactures instructions. The PBMCs were resuspended to
5.0610
6 cells/ml in RPMI 1640 supplemented with 2% v/v of
homologous serum (from the same animal as the PBMCs) and
30 mg/ml of penicillin. Cells (1 ml) were seeded into 24 well tissue
plates. After overnight incubation, cells were stimulated with 50 ml
of SDS-PAGE derived fractions, 5.0610
6 S. suis bacteria (in
presence or absence penicillin), or 50 mlo fS. suis derived bacterial
supernatant. After stimulation (2 and 4 h) cells were lysed and
frozen (280uC) and stored until RNA isolation and cytokine
detection. We used quantitative real time PCR analysis, because
the available porcine cytokine ELISAs are much less sensitive,
particularly for stimulation experiments that last only 2–4 h. FSL-
1 (100 ng/ml) and medium-stimulated cells served as positive and
negative controls, respectively.
RNA isolation, cDNA synthesis, and quantitative real time
PCR
Total RNA was isolated with the High Pure RNA Isolation Kit
(Roche Diagnostics, Mannheim, Germany), according the man-
ufactures instructions. RNA quantity and quality was checked with
the NANOdrop (Thermo Fisher Scientific, Pitsburgh, USA). To
make cDNA, 200 ng RNA was reverse transcribed using OligoDt
and Superscript III (Promega), according the manufactures
instructions. For quantitative real time PCR analysis of IL-1b
and IL-8 cytokines, 5 ml of 20 times diluted cDNA was added to
16power cyber green mixture (Applied Biosystems, Nieuwe Kerk
aan de IJssel, The Netherlands) containing 0.625 mM of forward
and reverse primer (Table S2) in a total of 20 ml. Serial dilutions of
pGemTeasy plasmids containing the PCR fragment of interest
were used as internal standards. The PCR was performed on a
7500 Fast Real-Time PCR system (Applied Biosystems). The PCR
program consisted of a denaturation step at 95uC for 10 min
followed by 40 cycles of denaturation at 95uC for 15 sec,
annealing at 59uC for 30 sec, and elongation at 72uC for 36 sec.
Ct values for the tested cytokines in each sample were expressed as
cDNA quantity (ng) using the internal standards. Subsequently,
the IL-1b and IL-8 ng levels were normalized with the ng levels of
the house keeping gene gapdh. To calculate fold inductions,
normalized IL-1b and IL-8 levels of stimulated cells were divided
by normalized IL-1b and IL-8 levels of medium-stimulated control
cells.
Stimulation of human TLR2/6 transfected HeLa cells
The HeLa 57A cell line, stably transfected with a NF-kB
luciferase reporter construct [37], was generously provided by Dr.
R.T. Hay (Institute of Biomolecular Sciences, University of St.
Andrews, St. Andrews, Scotland, UK). Cells were propagated in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum (FBS) and incubated at 37uC and 10%
CO2. For transfection experiments, cells were seeded in 48 well
tissue culture plates. When 50% confluence was reached, cells
were transfected with 250 ng DNA/well using FuGENE 6 (Roche
Diagnostics, Almere, The Netherlands) at a lipid to DNA ratio of 3
to 1. For TLR2/6 transfection, expression plasmids carrying the
human TLR2, human TLR6 and human CD14 gene [22] were
used, kindly provided by Dr. A.M. Keestra (Utrecht University,
The Netherlands). Cells transfected with empty vector were used
as negative controls and the pTK-LacZ vector was used for
normalization of the transfection efficiency. After 48 h of
incubation at 37uC, medium was replaced with fresh medium
containing 30 mg/ml penicillin (Sigma-Aldrich). Subsequently,
cells were stimulated for 5 h with 2.0610
7/ml bacteria or with
50 ml of SDS-PAGE derived cell wall fractions. The di-acylated
lipopeptide FSL-1 (InvivoGen, Toulouse, France) (100 ng/ml)
served as a TLR2/6 specific control. After stimulation, cells
were washed twice with D-PBS and lysed in 0.1 ml of passive
Reporter Lysis Buffer (Promega), according the manufactures
description. Subsequently, luciferase activity was determined with
a Victor 1420 multilabel counter (PerkinElmer, Groningen, The
Netherlands) by incubating 20 ml of lysed cells with 50 mlo f
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normalized for transfection efficiency by determination of ß-
galactosidase activity with the ß-galactosidase assay (Promega).
Relative fold activation was calculated as the normalized reporter
activity of the test samples divided by the normalized activity of
medium-stimulated control cells.
Statistical analysis
Statistical analysis was performed in GraphPad Prism. Normal
distribution of data was evaluated using Kolmogorov-Smirnov
test. Subsequently, normal distributed data were analyzed using an
unpaired Students’s t test and non-normal distributed data were
analyzed using the Mann-Whitney test. P-values ,0.05 were taken
as significant.
Supporting Information
Figure S1 IL-6, TNF-a and IL-10 cytokine responses of
porcine PBMCs stimulated with wild type S. suis. Porcine
PBMCs were stimulated with whole S. suis strain 8067 bacteria
(cells) in the presence of penicillin or with supernatant (sup.)
derived from penicillin treated bacteria. At 2 (light grey bar) and
4 h (dark grey bar) post stimulation IL-6 (A), TNF-a (B) and IL-10
(C) mRNA expression levels were determined by quantitative real
time PCR. The diacylated lipopeptide FSL was used as a positive
control. Data represent fold inductions calculated by dividing the
normalized cytokine levels of stimulated cells by the normalized
cytokine levels of medium-stimulated negative control cells. Values
represent the mean 6 SD of two experiments performed in
duplicate.
(TIF)
Table S1 Putative lipoproteins of S. suis strain P1/7.
(DOC)
Table S2 Primer sequences.
(DOC)
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